Related Experiment Video

Updated: Aug 16, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Usnic acid: a non-genotoxic compound with anti-cancer properties

Margareth Mayer1, Mary A O'Neill, Karen E Murray

  • 1Departamento de Morfologia e Fisiologia Animal, Universidade Federal de Pernambuco, Recife, PE, Brasil.

Anti-Cancer Drugs
|August 13, 2005
PubMed

Insights

Usnic acid, a lichen compound, shows anti-cancer effects independent of the p53 pathway. This makes it a promising candidate for novel cancer therapies, especially for tumors with inactive p53.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Many human tumors have inactive p53 or related factors, limiting therapeutic options.
  • Developing effective therapies for these p53-deficient tumors is a significant challenge in cancer research.

Purpose of the Study:

  • To investigate the anti-cancer potential of usnic acid, a lichen-derived compound.
  • To determine if usnic acid's anti-cancer activity is dependent on the p53 pathway.

Main Methods:

  • Usnic acid was tested against breast cancer cell lines (MCF7, MDA-MB-231) and a lung cancer cell line (H1299) with varying p53 statuses.
  • Protein levels of p53 and p21 were analyzed post-treatment.
  • p53 transcriptional activity and phosphorylation at Ser15 were assessed.

Main Results:

  • Usnic acid demonstrated anti-cancer activity across cell lines with wild-type, non-functional, and null p53.
  • Treatment led to p53 and p21 protein accumulation but did not affect p53 transcriptional activity.
  • No p53 phosphorylation at Ser15 was observed, indicating a lack of DNA damage.

Conclusions:

  • Usnic acid exhibits anti-cancer properties through a p53-independent mechanism.
  • Its non-genotoxic nature and efficacy in p53-deficient models suggest potential as a novel cancer therapeutic agent.

More Related Videos

Generation of Monoclonal Antibodies Against Natural Products12:15

Generation of Monoclonal Antibodies Against Natural Products

Published on: April 6, 2019

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Physical Properties of Amines01:26

Physical Properties of Amines

Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
2° Amines to N-Nitrosamines: Reaction with NaNO201:20

2° Amines to N-Nitrosamines: Reaction with NaNO2

Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.